According to the WHO, the incidence of dengue has increased considerably in recent decades. Dengue is now endemic in more than 100 countries in Africa, the Americas, the Eastern Mediterranean, Southeast Asia, and the Western Pacific. Asia bears about 70% of the global burden of dengue. Dengue is no longer a regional health threat but a global health threat. The ASEAN dengue day theme for 2023 is “ASEANS commitment to fight against dengue.” There is no specific treatment for dengue. So far only one dengue vaccine CYD-TDV has been licensed for use. It is currently in use in about 20 countries globally. There are several candidate vaccines in different stages of development, some are currently in various stages of Clinical Trials. Several challenges have been faced in the development of the vaccines particularly the nature of the virus itself that has four major serotypes and the immune response to the vaccine itself.
At the ISID, we believe in supporting researchers from all over the world to work on infectious diseases including dengue. Our ISID Knowledge Exchange has several educational resources on dengue looking at several aspects of the disease:
Dengue Disease Awareness Webinar
Dengue Vaccines: Directions for the Future Webinar
And stay tuned for our upcoming webinar, "Treatment Strategies for Dengue Infection," on July 25, 2023.
Speakers:
- Ashley St. John, Singapore
- Eng Eong Ooi, Singapore
Chair: Neelika Malavige, Sri Lanka
Co-Chair: Muhammed Niyas, India
This webinar is supported by an unrestricted educational grant from Takeda.